drugset / Trial / NCT00857727

Use of Dexmedetomidine to Reduce Emergence Delirium Incident in Children

NCT00857727

Phase 3 Completed 33 enrolled St. Luke's-Roosevelt Hospital Center
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Emergence delirium (ED) from general anesthesia posts risk and harm to pediatric population undergo general anesthesia. The purpose of the study is to compare the use of dexmedetomidine versus placebo in reducing the incidence and severity of ED in a pediatric neurosurgical population.

Timeline

Start
2009-08
Primary completion
2011-11
Completion
2011-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 0.4 mg/kg
Subject Dexmedetomidine Other / unclassified 0.7 mg/kg

Indications

No indication recorded.